Stabilized amorphous forms of Imatinib mesylate

Details for Australian Patent Application No. 2012201613 (hide)

Owner Novartis AG

Inventors Goncalves, Elisabete; Lakshman, Jay Parthiban; Wirth, Wolfgang; Kalb, Oskar; Mutz, Michael

Agent Davies Collison Cave

Pub. Number AU-A-2012201613

Parent 2008262059

Filing date 19 March 2012

Wipo publication date 5 April 2012

International Classifications

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

5 April 2012 Application Open to Public Inspection

  Published as AU-A-2012201613

5 April 2012 Complete Application Filed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012201614-Board made from oil palm fiber and magnesium oxide and the manufacture process thereof

2012201612-Antifungal peptides